title: Efficacy of sertraline for bulimia nervosa.
abstract: OBJECTIVE
  The current study examined the efficacy of sertraline in the treatment of individuals diagnosed with bulimia nervosa.
  
  
  METHODS
  Eighteen women enrolled in an 8-week open trial of sertraline. Eating disorder psychopathology and depressive symptoms were assessed at baseline and at the end of the trial using both semistructured interviews and self-report questionnaires.
  
  
  RESULTS
  Findings indicated significant reductions in eating disorder psychopathology, including the number of binges and purges per week, as well as significant reductions in depressive symptoms. In addition, participants did not experience significant weight gain or any other sertraline side effect assessed at the end of the trial compared with baseline.
  
  
  CONCLUSIONS
  Findings from the current study indicate that sertraline is efficacious in the treatment of bulimia nervosa. A double-blind controlled trial of sertraline is recommended for future research.
authors.affiliation: Department of Psychology, Temple University, Philadelphia, Pennsylvania 19122, USA. dsloan@temple.edu
authors.forename: Denise M
authors.initials: DM
authors.lastname: Sloan
authors.forename: J Scott
authors.initials: JS
authors.lastname: Mizes
authors.forename: Craig
authors.initials: C
authors.lastname: Helbok
authors.forename: Rebekah
authors.initials: R
authors.lastname: Muck
mesh_terms: D000328:Adult; D015992:Body Mass Index; D002032:Bulimia / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline / Q000627:therapeutic use*; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline